Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001539937-25-000008
Filing Date
2025-08-27
Accepted
2025-08-27 16:56:07
Documents
1
Period of Report
2025-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1756328164.html 4  
1 FORM 4 wk-form4_1756328164.xml 4 8037
  Complete submission text file 0001539937-25-000008.txt   9583
Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Khattar Jack A. (Reporting) CIK: 0001539937 (see all company filings)